Foghorn Therapeutics Inc. (FHTX): Total Liabilities
$306.60M
As of 2025-12-31
$284.43M
As of 2026-06-30
-8.8%
3-year compound annual growth
+22.9%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $306.60M | -7.0% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $329.51M | -9.3% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $363.11M | -10.3% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $404.77M | -4.3% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $422.90M | +286.5% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $109.41M | +359.4% | 2022-08-09, Balance as of period end |
| 2019-12-31 | $23.81M | n/a | 2021-03-18, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $306.60M | -7.0% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $189.25M | +45.1% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $11.64M | -0.5% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $15.78M | +7.4% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $22.39M | -65.0% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.93M | -40.0% |
| Celularity Inc (CELU) | 2025-12-31 | $145.39M | +17.4% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $7.04M | -0.3% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $6.64M | -34.4% |
Compare FHTX, VSTM, ZOMDF, CUE side by side · Screen every company in Pharmaceutical Preparations ↗